General anaesthetics and oxygen Inhalational medicines halothane Inhalation. isoflurane Inhalation. nitrous oxide Inhalation. oxygen Inhalation(medicinal gas). Injectable medicines ketamine Injection: 50mg (as hydrochloride)/ml in 10‐ml vial. propofol Injection: 10mg/ml;20mg/ml. Thiopental may be used as an alternative depending on local availability and cost. Local anaesthetics bupivacaine Injection: 0.25%; 0.5% (hydrochloride) in vial. Injection for spinal anaesthesia: 0.5% (hydrochloride) in 4‐ml ampoule to be mixed with 7.5% glucose solution. lidocaine Injection: 1%; 2% (hydrochloride)in vial Injection for spinal anaesthesia: 5% (hydrochloride) in 2‐ml ampoule to be mixed with 7.5% glucose solution. Topical forms: 2% to 4% (hydrochloride). lidocaine + epinephrine (adrenaline) Dental cartridge: 2% (hydrochloride) + epinephrine 1:80 000. Injection: 1%; 2% (hydrochlorid...
Posts
- Get link
- X
- Other Apps
1. Streptomycin: Acute infections: 1 g (0.75 g in those above 50 yr age) i.m. (15 mg/kg) BD for 7–10 days. Tuberculosis: 1 g or 0.75 g i.m. OD or twice weekly for 30–60 days; AMBISTRYN–S 0.75, 1 g dry powder per vial for inj. 2. Gentamicin: 3–5 mg/kg/day i.m. in a single dose or divided in 8 hourly doses (dose reduction needed in elderly and in renal insufficiency), 0.1–0.3% topically in eye or on skin. GARAMYCIN, GENTASPORIN, GENTICYN 20, 60, 80, 240 mg per vial inj; also 0.3% eye/ear drops, 0.1% skin cream. 3. Kanamycin: 0.5 g i.m. BD–TDS: KANAMYCIN, KANCIN, KANAMAC 0.5, 1 g inj. 4. Tobramycin: 3–5 mg/kg day i.m. in 1–3 doses; TOBACIN 20, 60, 80 mg in 2 ml inj. 0.3% eye drops. TOBRANEG 20, 40, 80 mg per 2 ml inj., TOBRABACT 0.3% eye drops. 5. Amikacin: 15 mg/kg/day i.m. in 1–3 doses; urinary tract infection 7.5 mg/kg/day; AMICIN, MIKACIN, MIKAJECT 100 mg, 250 mg, 500 mg in 2 ml inj. 6. Sisomicin: 3–5 mg/kg/day i.m.; ENSAMYCIN...
- Get link
- X
- Other Apps
Note: Insert CTC proposed in Cell # E15 C o m p o n e n t s % a g e M o n t h l y A n n u a l B a s i c P a y 4 0 20,667 248,000 H o u s e R e n t A l l o w a n c e 1 2 6,200 74,400 S p e c i a l A l l o w a n c e 1 703 8,440 C a r L e a s e O p t i o n 2 9 15,000 180,000 L e a v e T r a v e l A l l o w a n c e ( L T A ) - - - C o n v e y a n c e A l l o w a n c e 8 0 0 9,600 M e d i c a l A l l o w a n c e 1 , 2 5 0 15,000 M e a l V o u c h e r s 1 , 1 0 0 13,200 E S I C o n t r i b u t i o n b y E m p l o y e r - - P F C o n t r i u b t i o n b y E m p l o y e r 7 8 0 9,360 Y e a r l y P e r f o r m a n c e B o n u s 5 , 1 6 7 62,000 620,000 G r o s s C T C 1 0 0 51,667 620,000 - P r o f e s s i o n s T a x 1 8 3 2,190 P F C o n t r i u b t i o n b y E m p l o y e r 7 8 0 9,360 P F C o n t r i u b t i o n b y E m p l o y e e 7 8 0 9,360 E S I ...
releving letter
- Get link
- X
- Other Apps
This is to inform you that your resignation has been accepted and you are relieved from the services of laborate pharma on the close of working hours on 5 july 2018. You are requested to deposit the company Id .We wish you all success in your future endeavors. Best Wishes, ALL THE BEST. TO WHOMSOVER IT MAY CONCERN This is to certify that Mr. BHUPESH SOLANKI was working at LABORATE PHARMACEUTICAL INDIA LTDAs PRODUCTION CHMIST from 1 JUNE 2017 to 5 JULY 2018. During his tenure, we found him to be good knowledge and good practice his services were found to be satisfactory. We wish him all the best in his future endeavors